Mert Simsek1, Pinar Cakar Ozdal2, Filiz Akbiyik3, Mehmet Citirik2, Nilufer Berker2, Yasemin Ozdamar Erol2, Pelin Yilmazbas2. 1. Department of Ophthalmology, Ulucanlar Eye Education and Research Hospital, University of Health Sciences, Kale Mahallesi, Ulucanlar Caddesi, No:59, 06250, Altındağ/Ankara, Turkey. mertsimsek86@gmail.com. 2. Department of Ophthalmology, Ulucanlar Eye Education and Research Hospital, University of Health Sciences, Kale Mahallesi, Ulucanlar Caddesi, No:59, 06250, Altındağ/Ankara, Turkey. 3. Department of Medical Biochemistry, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Abstract
PURPOSE: This study investigated the levels of interleukin (IL)-8, IL-10, and vascular endothelial growth factor (VEGF) in the aqueous humor (AqH) of patients with Behçet's uveitis (BU) and Fuchs' uveitis syndrome (FUS) during an inactive period and compared these levels with those in the AqH of noninflammatory healthy control subjects. METHODS: This prospective and case-control study included 33 patients (16 patients with BU and 17 patients with FUS) and 35 control subjects. IL-8, IL-10, and VEGF levels in the AqH were quantified by performing sandwich enzyme-linked immunosorbent assay. Kruskal-Wallis test was used to compare the cytokine levels in the different groups, and statistical significance was set at p < 0.05. RESULTS: IL-8 levels were significantly higher in the AqH of patients with BU and FUS than in the AqH of control subjects (p < 0.001 and p < 0.001, respectively). IL-10 levels were significantly lower in the AqH of patients with BU than in the AqH of patients with FUS and of control subjects (p = 0.001 and p < 0.001, respectively). Although VEGF levels were higher in the AqH of patients with FUS than in the AqH of patients with BU and of control subjects, the difference was significant only between patients with FUS and control subjects (p < 0.001). CONCLUSIONS: We observed a significant decrease in IL-10 levels in the AqH of patients with BU and a significant increase in VEGF levels in the AqH of patients with FUS compared to controls. IL-8 and VEGF levels showed no significant difference among uveitis patients.
PURPOSE: This study investigated the levels of interleukin (IL)-8, IL-10, and vascular endothelial growth factor (VEGF) in the aqueous humor (AqH) of patients with Behçet's uveitis (BU) and Fuchs' uveitis syndrome (FUS) during an inactive period and compared these levels with those in the AqH of noninflammatory healthy control subjects. METHODS: This prospective and case-control study included 33 patients (16 patients with BU and 17 patients with FUS) and 35 control subjects. IL-8, IL-10, and VEGF levels in the AqH were quantified by performing sandwich enzyme-linked immunosorbent assay. Kruskal-Wallis test was used to compare the cytokine levels in the different groups, and statistical significance was set at p < 0.05. RESULTS:IL-8 levels were significantly higher in the AqH of patients with BU and FUS than in the AqH of control subjects (p < 0.001 and p < 0.001, respectively). IL-10 levels were significantly lower in the AqH of patients with BU than in the AqH of patients with FUS and of control subjects (p = 0.001 and p < 0.001, respectively). Although VEGF levels were higher in the AqH of patients with FUS than in the AqH of patients with BU and of control subjects, the difference was significant only between patients with FUS and control subjects (p < 0.001). CONCLUSIONS: We observed a significant decrease in IL-10 levels in the AqH of patients with BU and a significant increase in VEGF levels in the AqH of patients with FUS compared to controls. IL-8 and VEGF levels showed no significant difference among uveitispatients.
Authors: Ahmed M Abu El-Asrar; Saleh S Al-Obeidan; Dustan Kangave; Karel Geboes; Ghislain Opdenakker; Jo Van Damme; Sofie Struyf Journal: Immunobiology Date: 2011-04-07 Impact factor: 3.144
Authors: Ahmed M Abu El-Asrar; Sofie Struyf; Dustan Kangave; Saleh S Al-Obeidan; Ghislain Opdenakker; Karel Geboes; Jo Van Damme Journal: Clin Immunol Date: 2011-01-31 Impact factor: 3.969
Authors: S A Vinores; C C Chan; M A Vinores; D M Matteson; Y S Chen; D A Klein; A Shi; H Ozaki; P A Campochiaro Journal: J Neuroimmunol Date: 1998-08-14 Impact factor: 3.478
Authors: Elaine F Remmers; Fulya Cosan; Yohei Kirino; Michael J Ombrello; Neslihan Abaci; Colleen Satorius; Julie M Le; Barbara Yang; Benjamin D Korman; Aris Cakiris; Oznur Aglar; Zeliha Emrence; Hulya Azakli; Duran Ustek; Ilknur Tugal-Tutkun; Gulsen Akman-Demir; Wei Chen; Christopher I Amos; Michael B Dizon; Afet Akdag Kose; Gulsevim Azizlerli; Burak Erer; Oliver J Brand; Virginia G Kaklamani; Phaedon Kaklamanis; Eldad Ben-Chetrit; Miles Stanford; Farida Fortune; Marwen Ghabra; William E R Ollier; Young-Hun Cho; Dongsik Bang; John O'Shea; Graham R Wallace; Massimo Gadina; Daniel L Kastner; Ahmet Gül Journal: Nat Genet Date: 2010-07-11 Impact factor: 38.330
Authors: Natasa Vidovic Valentincic; Jolanda D F de Groot-Mijnes; Aleksandra Kraut; Peter Korosec; Marko Hawlina; Aniki Rothova Journal: Mol Vis Date: 2011-07-20 Impact factor: 2.367
Authors: L De Simone; M Bonacini; S Croci; L Cimino; R Aldigeri; F Alessandrello; V Mastrofilippo; F Gozzi; E Bolletta; C Adani; A Zerbini; G M Cavallini; L Fontana; C Salvarani Journal: Inflamm Res Date: 2022-06-28 Impact factor: 6.986
Authors: Martina Bonacini; Alessandra Soriano; Luca Cimino; Luca De Simone; Elena Bolletta; Fabrizio Gozzi; Francesco Muratore; Maria Nicastro; Lucia Belloni; Alessandro Zerbini; Luigi Fontana; Carlo Salvarani; Stefania Croci Journal: Front Immunol Date: 2020-03-10 Impact factor: 7.561